337 related articles for article (PubMed ID: 32814140)
1. Steroid-eluting contact lenses for corneal and intraocular inflammation.
Bengani LC; Kobashi H; Ross AE; Zhai H; Salvador-Culla B; Tulsan R; Kolovou PE; Mittal SK; Chauhan SK; Kohane DS; Ciolino JB
Acta Biomater; 2020 Oct; 116():149-161. PubMed ID: 32814140
[TBL] [Abstract][Full Text] [Related]
2. Topical sustained drug delivery to the retina with a drug-eluting contact lens.
Ross AE; Bengani LC; Tulsan R; Maidana DE; Salvador-Culla B; Kobashi H; Kolovou PE; Zhai H; Taghizadeh K; Kuang L; Mehta M; Vavvas DG; Kohane DS; Ciolino JB
Biomaterials; 2019 Oct; 217():119285. PubMed ID: 31299627
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic modeling of ophthalmic drug delivery to the anterior chamber by eye drops and contact lenses.
Gause S; Hsu KH; Shafor C; Dixon P; Powell KC; Chauhan A
Adv Colloid Interface Sci; 2016 Jul; 233():139-154. PubMed ID: 26318359
[TBL] [Abstract][Full Text] [Related]
4. Controlled delivery of pirfenidone through vitamin E-loaded contact lens ameliorates corneal inflammation.
Dixon P; Ghosh T; Mondal K; Konar A; Chauhan A; Hazra S
Drug Deliv Transl Res; 2018 Oct; 8(5):1114-1126. PubMed ID: 29858820
[TBL] [Abstract][Full Text] [Related]
5. Inflammation-responsive molecular-gated contact lens for the treatment of corneal neovascularization.
Sun R; Ma S; Chen X; Deng Y; Gou J; Yin T; He H; Wang Y; Tang X; Zhang Y
J Control Release; 2023 Aug; 360():818-830. PubMed ID: 37481212
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of corneal drug delivery of cysteamine using vitamin E modified silicone hydrogel contact lenses.
Hsu KH; Fentzke RC; Chauhan A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):531-40. PubMed ID: 23665502
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of topical dexamethasone eye drops in preventing ocular inflammation and cystoid macular edema following uncomplicated cataract surgery with or without injection of a single dose perioperative subtenon triamcinolone acetonide.
Karasu B; Kesim E; Kaskal M; Celebi ARC
Cutan Ocul Toxicol; 2022 Dec; 41(4):310-317. PubMed ID: 36308286
[TBL] [Abstract][Full Text] [Related]
8. Establishing a Dexamethasone Treatment Regimen To Alleviate Sulfur Mustard-Induced Corneal Injuries in a Rabbit Model.
Mishra N; Kant R; Kandhari K; Tewari-Singh N; Anantharam P; Croutch CR; Pantcheva MB; Petrash JM; Araj H; Agarwal C; Agarwal R
J Pharmacol Exp Ther; 2024 Jan; 388(2):469-483. PubMed ID: 37316330
[TBL] [Abstract][Full Text] [Related]
9. Corneal delivery of moxifloxacin and dexamethasone combination using drug-eluting mucoadhesive contact lens to treat ocular infections.
Gade SK; Nirmal J; Garg P; Venuganti VVK
Int J Pharm; 2020 Dec; 591():120023. PubMed ID: 33127488
[TBL] [Abstract][Full Text] [Related]
10. Atropine-eluting silicone contact lenses for myopia control.
Fu Y; Luo Y; Chen X; Tong Y; Zhu Y; Yang L
J Biomater Appl; 2023 May; 37(10):1724-1735. PubMed ID: 37083186
[TBL] [Abstract][Full Text] [Related]
11. High drug payload nanoparticles formed from dexamethasone-peptide conjugates for the treatment of endotoxin-induced uveitis in rabbit.
Yu X; Zhang R; Lei L; Song Q; Li X
Int J Nanomedicine; 2019; 14():591-603. PubMed ID: 30666116
[TBL] [Abstract][Full Text] [Related]
12. In vitro drug release and in vivo safety of vitamin E and cysteamine loaded contact lenses.
Dixon P; Fentzke RC; Bhattacharya A; Konar A; Hazra S; Chauhan A
Int J Pharm; 2018 Jun; 544(2):380-391. PubMed ID: 29217475
[TBL] [Abstract][Full Text] [Related]
13. Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys.
Ciolino JB; Ross AE; Tulsan R; Watts AC; Wang RF; Zurakowski D; Serle JB; Kohane DS
Ophthalmology; 2016 Oct; 123(10):2085-92. PubMed ID: 27586444
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
[TBL] [Abstract][Full Text] [Related]
15. Calcium ion coordinated dexamethasone supramolecular hydrogel as therapeutic alternative for control of non-infectious uveitis.
Wu W; Zhang Z; Xiong T; Zhao W; Jiang R; Chen H; Li X
Acta Biomater; 2017 Oct; 61():157-168. PubMed ID: 28501709
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone-Eluting Contact Lens for the Prevention of Postphotorefractive Keratectomy Scar in a New Zealand White Rabbit Model.
Soeken TA; Ross AE; Kohane DS; Kuang L; Legault GL; Caldwell MC; Brundridge WL; Merkley MB; Ciolino JB; Townley JR
Cornea; 2021 Sep; 40(9):1175-1180. PubMed ID: 34294635
[TBL] [Abstract][Full Text] [Related]
17. Multiple drug delivery from the drug-implants-laden silicone contact lens: Addressing the issue of burst drug release.
Desai AR; Maulvi FA; Desai DM; Shukla MR; Ranch KM; Vyas BA; Shah SA; Sandeman S; Shah DO
Mater Sci Eng C Mater Biol Appl; 2020 Jul; 112():110885. PubMed ID: 32409042
[TBL] [Abstract][Full Text] [Related]
18. Inner layer-embedded contact lenses for pH-triggered controlled ocular drug delivery.
Zhu Q; Liu C; Sun Z; Zhang X; Liang N; Mao S
Eur J Pharm Biopharm; 2018 Jul; 128():220-229. PubMed ID: 29730260
[TBL] [Abstract][Full Text] [Related]
19. Phenylboronic acid-tethered chondroitin sulfate-based mucoadhesive nanostructured lipid carriers for the treatment of dry eye syndrome.
Tan G; Li J; Song Y; Yu Y; Liu D; Pan W
Acta Biomater; 2019 Nov; 99():350-362. PubMed ID: 31449929
[TBL] [Abstract][Full Text] [Related]
20. A novel approach to achieve semi-sustained drug delivery to the eye through asymmetric loading of soft contact lenses.
Sarmout M; Xiao Y; Hu X; Rakhmetova A; Koole LH
Heliyon; 2023 Jun; 9(6):e16916. PubMed ID: 37484374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
